Folic acid safety and toxicity: a brief review
- 1 August 1989
- journal article
- review article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 50 (2) , 353-358
- https://doi.org/10.1093/ajcn/50.2.353
Abstract
Oral folic acid (pteroylglutamic acid) is generally regarded as not toxic for normal humans but it may cause neurological injury when given to patients with undiagnosed pernicious anemia. The vitamin should be given with caution to drug-treated epileptic patients because seizure control may be affected. Some studies suggest that folic acid supplements interfere with intestinal zinc absorption in humans and animals but others do not confirm such an effect. The weight of current evidence favors the view that daily supplements of 5–15 mg folic acid do not have significant adverse effects on Zn nutriture in healthy nonpregnant subjects. Because antifolate medications are now being used to treat a wide range of malignant and nonmalignant disorders, further investigation is needed concerning folate metabolism and the safety of supplements in patients with these disorders.Keywords
This publication has 39 references indexed in Scilit:
- Methotrexate in the Treatment of Corticosteroid-Dependent AsthmaNew England Journal of Medicine, 1988
- The effects of dietary folate and zinc on the outcome of pregnancy and early growth in ratsBritish Journal of Nutrition, 1988
- Trimetrexate for the Treatment ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Inhibition of Folate Enzymes by SulfasalazineJournal of Clinical Investigation, 1978
- Vitamin ToxicityAnnual Review of Pharmacology and Toxicology, 1977
- FOLIC ACID: LACK OF TOXICITYThe Lancet, 1973
- TOXICITY OF FOLIC ACIDThe Lancet, 1971
- LACK OF TOXICITY OF FOLIC ACID GIVEN IN PHARMACOLOGICAL DOSES TO HEALTHY VOLUNTEERSThe Lancet, 1971
- Megaloblastic Anaemia Due to PhenobarbitoneBMJ, 1960
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948